Recent Advances in Prostate Cancer Treatment and Drug Discovery

Recent Advances in Prostate Cancer Treatment and Drug Discovery

Novel drugs, drug sequences and combinations have improved the outcome of prostate cancer in recent years. The latest approvals include abiraterone acetate, enzalutamide and apalutamide which target androgen receptor (AR) signaling, radium-223 dichloride for reduction of bone metastases, sipuleucel-...

Full description

Bibliographic Details
Main Authors:	Ekaterina Nevedomskaya, Simon J. Baumgart, Bernard Haendler
Format:	Article
Language:	English
Published:	MDPI AG 2018-05-01
Series:	International Journal of Molecular Sciences
Subjects:	prostate cancer androgen receptor PI3K pathway DNA repair “omics” technologies
Online Access:	http://www.mdpi.com/1422-0067/19/5/1359

Similar Items

Exploiting Epigenetic Alterations in Prostate Cancer
by: Simon J. Baumgart, et al.
Published: (2017-05-01)

Metastatic castration-resistant prostate cancer: a current view on drug therapy and alternative tumor cell regulation
by: R. A. Gafanov, et al.
Published: (2018-04-01)

Genomic analysis of DNA repair genes and androgen signaling in prostate cancer
by: Kasey Jividen, et al.
Published: (2018-10-01)

Dysregulated Transcriptional Control in Prostate Cancer
by: Simon J. Baumgart, et al.
Published: (2019-06-01)

Darolutamide antagonizes androgen signaling by blocking enhancer and super‐enhancer activation
by: Simon J. Baumgart, et al.
Published: (2020-09-01)

The role of mRNA splicing in prostate cancer
by: Anna V Lapuk, et al.
Published: (2014-08-01)

Tangeretin prevents prostate cancer cell proliferation and induces apoptosis via activation of Notch signalling and regulating the androgen receptor (AR) pathway and the phosphoinositide 3-kinase (PI3k)/Akt/mTOR pathways
by: Jin-Jin Guo, et al.
Published: (2015-11-01)

New Prognostic Biomarkers in Metastatic Castration-Resistant Prostate Cancer
by: Vincenza Conteduca, et al.
Published: (2021-01-01)

Targeting DNA Damage Response in Prostate and Breast Cancer
by: Antje M. Wengner, et al.
Published: (2020-11-01)

Targeting the EBFR and PI3K pathways as a therapeutic strategy for prostate cancer
by: Maleka, Sechaba
Published: (2015)

Crosstalk Between AR and Wnt Signaling Promotes Castration-Resistant Prostate Cancer Growth
by: Luo J, et al.
Published: (2020-09-01)

PI3K-AKT-mTOR signaling in prostate cancer progression and androgen deprivation therapy resistance
by: Merritt P Edlind, et al.
Published: (2014-06-01)

Maximal androgen blockade for advanced prostate cancer
by: Rajiv Paul Mukha, et al.
Published: (2010-01-01)

Omics Derived Biomarkers and Novel Drug Targets for Improved Intervention in Advanced Prostate Cancer
by: Maria Frantzi, et al.
Published: (2020-08-01)

Expanding armamentarium in advanced prostate cancer management: are all novel antiandrogens the same?
by: Emre Yekedüz, et al.
Published: (2021-03-01)

Prostate Cancer in 2021: Novelties in Prognostic and Therapeutic Biomarker Evaluation
by: Alessia Cimadamore, et al.
Published: (2021-07-01)

Hormonal Therapies for Patients with Advanced Prostate Cancer
by: Cora N. Sternberg, et al.
Published: (2016-01-01)

Wnt/β-catenin signal transduction pathway in prostate cancer and associated drug resistance
by: Chunyang Wang, et al.
Published: (2021-10-01)

Plasma Androgen Receptor in Prostate Cancer
by: Vincenza Conteduca, et al.
Published: (2019-11-01)

Overexpression of IGFBP5 Enhances Radiosensitivity Through PI3K-AKT Pathway in Prostate Cancer
by: Chen X, et al.
Published: (2020-07-01)

Mechanisms of Resistance to PI3K Inhibitors in Cancer: Adaptive Responses, Drug Tolerance and Cellular Plasticity
by: Sarah Christine Elisabeth Wright, et al.
Published: (2021-03-01)

A feedback loop between the androgen receptor and 6-phosphogluoconate dehydrogenase (6PGD) drives prostate cancer growth
by: Joanna L Gillis, et al.
Published: (2021-08-01)

Androgen receptor and prostate cancer
by: Karen E. Livermore, et al.
Published: (2016-06-01)

Crosstalk between signaling pathways in hormonal progression of prostate cancer
by: Wang, Gang
Published: (2009)

Crosstalk between signaling pathways in hormonal progression of prostate cancer
by: Wang, Gang
Published: (2009)

Crosstalk between signaling pathways in hormonal progression of prostate cancer
by: Wang, Gang
Published: (2009)

Role of maximum androgen blockade in advanced prostate cancer
by: Rajinikanth Ayyathurai, et al.
Published: (2009-01-01)

Interaction entre la voie Hedgehog et les hormones stéroïdiennes dans les cellules normales et cancéreuses de la prostate
by: Sirab, Nanour
Published: (2010)

Androgen Receptor Roles in Benign and Malignant Prostate Disease
Published: (2011-06-01)

Inhibition of PI3K-AKT-mTOR pathway sensitizes endometrial cancer cell lines to PARP inhibitors
by: Charles-André Philip, et al.
Published: (2017-09-01)

Breviscapine suppresses the growth and metastasis of prostate cancer through regulating PAQR4-mediated PI3K/Akt pathway
by: Jiwei Ye, et al.
Published: (2020-07-01)

Oncogenic activation in prostate cancer progression and metastasis: Molecular insights and future challenges
by: Subhamoy Dasgupta, et al.
Published: (2012-01-01)

Economical impact of orchiectomy for advanced prostate cancer
by: Paula Adriano A. P. de, et al.
Published: (2003-01-01)

SMARCC1 Suppresses Tumor Progression by Inhibiting the PI3K/AKT Signaling Pathway in Prostate Cancer
by: Zhao-Ming Xiao, et al.
Published: (2021-06-01)

Recent Discoveries in the Androgen Receptor Pathway in Castration-Resistant Prostate Cancer
by: Daisuke Obinata, et al.
Published: (2020-10-01)

Clamp ablation of the testes compared to bilateral orchiectomy as androgen deprivation therapy for advanced prostate cancer
by: AD Zarrabi, et al.
Published: (2011-06-01)

A hnRNP K–AR-Related Signature Reflects Progression toward Castration-Resistant Prostate Cancer
by: Matteo Capaia, et al.
Published: (2018-06-01)

Hormonal status in patients with advanced prostatic cancer on the therapy with androgen blockade
by: Vojinov Saša, et al.
Published: (2011-01-01)

Therapies Targeted to Androgen Receptor Signaling Axis in Prostate Cancer: Progress, Challenges, and Hope
by: Sirin Saranyutanon, et al.
Published: (2019-12-01)

Testosterone replacement and prostate cancer
by: Ranjith Ramasamy, et al.
Published: (2012-01-01)